IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Krensavage Asset Management, LLC

Q2 2023 Holdings

Filed 2023-08-11 | 12 holdings | $50.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Biogen Inc(BIIB)COM09062X103$50.4M176,82699.5%
United Therapeutics Corp(UTHR)COM91307C102$44.7K202,7150.1%
Regeneron Pharmaceuticals(REGN)COM75886F107$42.5K59,1880.1%
Exelixis Inc(EXEL)COM30161Q104$40.8K2,133,7030.1%
Alkermes PLC(ALKS)COMG01767105$34.5K1,103,4510.1%
Cardinal Health Inc(CAH)COM14149Y108$33.5K353,7140.1%
Taro Pharmaceutical IndusCOMM8737E108$24.4K643,0800.0%
Embecta Corp(EMBC)COM29082K105$23.1K1,070,8100.0%
Enanta Pharmaceuticals Inc(ENTA)COM29251M106$14.7K687,6130.0%
Vanda Pharmaceuticals Inc(VNDA)COM921659108$2.4K362,9510.0%
Kodiak Sciences Inc(KOD)COM50015M109$2.4K344,6340.0%
Eagle Pharmaceuticals Inc(EGRX)COM269796108$2.2K113,4370.0%